C3HARME focused on next-generation ceramic composites for combustion harsh environments and space; I.FAST involves materials for accelerator components.
NANOKER RESEARCH SL
Spanish SME producing advanced ceramic and nanocomposite materials for extreme environments — from combustion chambers and fusion reactors to dental implants.
Their core work
Nanoker Research is a Spanish SME specializing in advanced ceramic and nanocomposite materials engineered for extreme operating conditions. Their work spans ceramic composites for high-temperature combustion and space environments, ceramic-based dental and medical devices, and precision ceramic components for scientific infrastructure such as particle accelerators. The company bridges materials science with commercial applications, translating advanced ceramic formulations into products for healthcare, energy, and big science sectors.
What they specialise in
INPERIO (coordinator, EUR 1.9M) developed a non-invasive ceramic solution for periodontal and peri-implant diseases.
Contributed to EUROfusion (fusion roadmap) and I.FAST (accelerator innovation), supplying advanced materials for large-scale research facilities.
I.FAST (2021-2025) involves superconductivity, synchrotron, and collider technologies — a new direction for the company.
How they've shifted over time
Nanoker's early H2020 work (2014-2018) centered on established advanced ceramics applications — contributing materials expertise to the EUROfusion programme and developing ceramic composites for harsh combustion and space environments in C3HARME. From 2018 onward, they pivoted into two new directions: biomedical ceramics (leading the INPERIO dental device project) and scientific infrastructure materials for particle accelerators (I.FAST). This evolution shows a company expanding from industrial ceramics into both healthcare and big science applications.
Nanoker is diversifying from traditional high-temperature ceramics into medical devices and particle physics infrastructure, suggesting growing capability in precision-engineered ceramic components for regulated and scientific markets.
How they like to work
Nanoker operates flexibly across roles — they have coordinated one major project (INPERIO, their largest by far at EUR 1.9M), participated as a partner in two others, and contributed as a third party to EUROfusion. With 252 unique consortium partners across 28 countries, they are well-networked relative to their size. Their willingness to join very large consortia (EUROfusion, I.FAST) alongside leading their own SME instrument project suggests an adaptable partner comfortable in both specialist contributor and leadership roles.
Despite being a small company with only 4 H2020 projects, Nanoker has collaborated with 252 unique partners across 28 countries — largely because their consortium memberships include massive pan-European programmes like EUROfusion and I.FAST. This gives them unusually broad visibility across European research infrastructure networks.
What sets them apart
Nanoker occupies a rare niche as an SME that produces advanced ceramic and nanocomposite materials validated across wildly different application domains — from fusion reactors and particle accelerators to dental implants. Few small companies can credibly supply materials for both CERN-scale infrastructure and medical devices. Their ability to coordinate a EUR 1.9M SME Instrument project demonstrates commercialization capability, not just research participation.
Highlights from their portfolio
- INPERIOTheir largest project (EUR 1.9M) and only coordination role — a commercial ceramic dental device, showing direct product development capability via the SME Instrument.
- C3HARMECore materials expertise on display: next-generation ceramic composites designed to survive combustion and space environments.
- I.FASTMost recent project connecting Nanoker to the particle accelerator community, with keywords in superconductivity and synchrotron technology — signals a new market direction.